Literature DB >> 30343239

RNA-Seq blood transcriptome profiling in familial attention deficit and hyperactivity disorder (ADHD).

Gustavo Lorenzo1, Jorge Braun2, Gonzalo Muñoz2, Maria J Casarejos2, Eulalia Bazán2, Adriano Jimenez-Escrig3.   

Abstract

We have carried an exploratory study by blood transcriptome to find RNA expression signatures in familial ADHD. Samples were collected from three cases with familial ADHD and their paired controls and evaluated by RNA-Seq. Transcriptome profiling identified 7 differentially expressed transcripts with a FDR <0.05 that were involved in pathways in Huntington's disease or axonal guidance signaling previously implicated in ADHD, and enriched for signal peptide, growth factor binding, and notably the lipid metabolism pathways. These findings show that blood transcriptome can have an associated signature and highlight a potential to use blood transcriptome to identify patterns of ADHD.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarkers; Lipid metabolism

Mesh:

Substances:

Year:  2018        PMID: 30343239     DOI: 10.1016/j.psychres.2018.10.025

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

Review 1.  Advancements in Genomic and Behavioral Neuroscience Analysis for the Study of Normal and Pathological Brain Function.

Authors:  Annalisa M Baratta; Adam J Brandner; Sonja L Plasil; Rachel C Rice; Sean P Farris
Journal:  Front Mol Neurosci       Date:  2022-06-23       Impact factor: 6.261

2.  Comprehensive analysis of omics data identifies relevant gene networks for Attention-Deficit/Hyperactivity Disorder (ADHD).

Authors:  Judit Cabana-Domínguez; María Soler Artigas; Lorena Arribas; Silvia Alemany; Laura Vilar-Ribó; Natalia Llonga; Christian Fadeuilhe; Montse Corrales; Vanesa Richarte; Josep Antoni Ramos-Quiroga; Marta Ribasés
Journal:  Transl Psychiatry       Date:  2022-09-24       Impact factor: 7.989

3.  Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish.

Authors:  Shiho Suzuki; Ryo Kimura; Shingo Maegawa; Masatoshi Nakata; Masatoshi Hagiwara
Journal:  Mol Brain       Date:  2020-05-06       Impact factor: 4.041

4.  Biomarker discovery in attention deficit hyperactivity disorder: RNA sequencing of whole blood in discordant twin and case-controlled cohorts.

Authors:  Timothy A McCaffrey; Georges St Laurent; Dmitry Shtokalo; Denis Antonets; Yuri Vyatkin; Daniel Jones; Eleanor Battison; Joel T Nigg
Journal:  BMC Med Genomics       Date:  2020-10-28       Impact factor: 3.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.